IT1172264B - Enzima simile a pepsina da leucocito umano,procedimento per prepararlo,e composizione terapeutica che lo continene come ingrediente attivo - Google Patents

Enzima simile a pepsina da leucocito umano,procedimento per prepararlo,e composizione terapeutica che lo continene come ingrediente attivo

Info

Publication number
IT1172264B
IT1172264B IT8348383A IT4838383A IT1172264B IT 1172264 B IT1172264 B IT 1172264B IT 8348383 A IT8348383 A IT 8348383A IT 4838383 A IT4838383 A IT 4838383A IT 1172264 B IT1172264 B IT 1172264B
Authority
IT
Italy
Prior art keywords
pepsin
continues
prepare
procedure
active ingredient
Prior art date
Application number
IT8348383A
Other languages
English (en)
Other versions
IT8348383A0 (it
Inventor
Haruo Ohnishi
Hiroshi Kosuzume
Yasuo Suzuki
Ei Mochida
Original Assignee
Mochida Pharm Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mochida Pharm Co Ltd filed Critical Mochida Pharm Co Ltd
Publication of IT8348383A0 publication Critical patent/IT8348383A0/it
Application granted granted Critical
Publication of IT1172264B publication Critical patent/IT1172264B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6478—Aspartic endopeptidases (3.4.23)
    • C12N9/6481—Pepsins (3.4.23.1; 3.4.23.2; 3.4.23.3)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IT8348383A 1982-05-31 1983-05-27 Enzima simile a pepsina da leucocito umano,procedimento per prepararlo,e composizione terapeutica che lo continene come ingrediente attivo IT1172264B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP1982/000213 WO1983004260A1 (en) 1982-05-31 1982-05-31 Human leukocyte pepsin-like enzyme, and a therapeutic agent containing said enzyme as effective ingredient for treating allergic disorder, immune complex disease, and tumor

Publications (2)

Publication Number Publication Date
IT8348383A0 IT8348383A0 (it) 1983-05-27
IT1172264B true IT1172264B (it) 1987-06-18

Family

ID=13762278

Family Applications (1)

Application Number Title Priority Date Filing Date
IT8348383A IT1172264B (it) 1982-05-31 1983-05-27 Enzima simile a pepsina da leucocito umano,procedimento per prepararlo,e composizione terapeutica che lo continene come ingrediente attivo

Country Status (11)

Country Link
US (1) US4591504A (it)
AU (2) AU8459882A (it)
BE (1) BE896895A (it)
CA (1) CA1207262A (it)
DE (1) DE3319360C2 (it)
FR (1) FR2527630B1 (it)
GB (1) GB2125046B (it)
IT (1) IT1172264B (it)
NL (1) NL8301934A (it)
SE (1) SE8303050L (it)
WO (1) WO1983004260A1 (it)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5995221A (ja) * 1982-11-20 1984-06-01 Mochida Pharmaceut Co Ltd 食細胞機能調節作用を有する医薬組成物
ES2054641T3 (es) * 1987-09-30 1994-08-16 Mucos Emulsions Gmbh Utilizacion de enzimas catabolicas para la preparacion de un medicamento destinado a combatir la inmunodeficiencia adquirida (sida) y sus etapas previas (sla y crs).
ES2038546B1 (es) * 1991-11-08 1994-02-16 Andromaco Lab Procedimiento de obtencion de un producto de naturaleza polipeptidica con actividad inhibidora de la hiperproduccion del factor de necrosis tumoral.
JP2711436B2 (ja) * 1995-02-22 1998-02-10 マルホ株式会社 アレルギー治療剤及びアレルギー対応食品

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2119872A1 (fr) * 1970-12-30 1972-08-11 Kuban Med I Im Krasnoi Armii Produit a base de pepsine,notamment pour le traitement des maladies s'accompagnant d'une insuffisance secretoire de l'estomac
US3796636A (en) * 1972-07-14 1974-03-12 Wilson Pharm & Chem Corp Process for preparing high activity pepsin
US4229540A (en) * 1979-07-02 1980-10-21 Cutter Laboratories, Inc. Hydrolase purified from human plasma

Also Published As

Publication number Publication date
GB2125046A (en) 1984-02-29
AU1507283A (en) 1984-01-19
SE8303050D0 (sv) 1983-05-30
SE8303050L (sv) 1983-12-01
FR2527630A1 (fr) 1983-12-02
GB8314727D0 (en) 1983-07-06
DE3319360C2 (de) 1986-10-09
NL8301934A (nl) 1983-12-16
DE3319360A1 (de) 1983-12-01
AU8459882A (en) 1983-12-16
BE896895A (fr) 1983-09-16
AU547166B2 (en) 1985-10-10
US4591504A (en) 1986-05-27
GB2125046B (en) 1985-08-07
FR2527630B1 (fr) 1986-07-11
CA1207262A (en) 1986-07-08
WO1983004260A1 (en) 1983-12-08
IT8348383A0 (it) 1983-05-27

Similar Documents

Publication Publication Date Title
IT1218469B (it) Polipeptide umano fisiologicamente ettivo
IT8522574A0 (it) Composizione farmaceutica eprocedimento per trattare il corpo umano con essa.
IT8467445A1 (it) Composizione e preparato per la somministrazione di medicamenti per via cutanea.
DE3587741T2 (de) Behandlung von Hautkrankheiten.
EE9900428A (et) Köhavastased ravimkoostised
NO861976L (no) Kosmetiske preparater for regenerering og hydratisering av hud samt fremgangsmaate for fremstilling av den aktive bestanddel.
NO910874D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive piperidinderivater.
IT8223017A0 (it) Formulazioni farmaceutiche comprendenti insulina umana e c-peptide umano.
SE8603086L (sv) Hudregenererande kosmetisk komposition
DK0613368T3 (da) Hudregenererende kosmetisk sammensætning
IT1172264B (it) Enzima simile a pepsina da leucocito umano,procedimento per prepararlo,e composizione terapeutica che lo continene come ingrediente attivo
IL69795A (en) Ophthalmic preparations containing as active ingredient 2-mercaptoalkanoyl peptides
IT1229223B (it) Composizioni veterinarie sinergisticamente attive e procedimento per la loro preparazione.
DE3687233T2 (de) Pharmazeutische zusammensetzungen zur behandlung von hautkrankheiten.
DK392288A (da) Human monoklonale antistoffer samt profylaktiske og terapeutiske midler mod infrektioese sygdomme, der indeholder samme som aktiv bestanddel
IT8222911A0 (it) Derivati della 1-metil-5-nitro-imidazolina e composizioni terapeutiche che li comprendono come principio attivo.
IT8521528A0 (it) Composizioni farmaceutiche e cosmetiche contenenti come ingrediente attivo diidrossi-1,8fenil-10 antrone-9, e procedimentodi preparazione dell'ingrediente attivo.
IT8319401A0 (it) Peptide e agente ormonale contenente lo stesso come ingrediente attivo.
OA09771A (en) Asphodelus composition for increasing white blood cell count.
IT8219652A0 (it) Derivato della propionilglicina, processi per la sua preparazione e composizioni terapeutiche che lo contengono come principio attivo.
IT7830630A0 (it) Prodotto ad attivita' coleretica e composizioni terapeutiche che lo comprendono come principio attivo.
IT8026351A0 (it) Derivato della ammino-penicillina, processo per la sua preparazione e composizioni terapeutiche che lo comprendono come principio attivo.
IT8719704A0 (it) Difluoroalometossifenil-derivato e miticida che contiene detto derivato come ingrediente attivo
IT8120177A0 (it) Derivato della l-prolina, processo per la sua preparazione e composizioni terapeutiche che lo comprendono come principio attivo.
IT1232796B (it) Composizioni sinergisticamente attive e procedimento per la loro preparazione.